Natco Pharma posts over two-fold jump in Q2 PAT to ₹ 181.6 crore
Natco Pharma reported over two-fold increase in consolidated profit after tax at ₹ 181.6 crore for the second quarter ended September 30, 2018. The company had posted a consolidated profit after tax of ₹ 84.4 crore in the same quarter last fiscal, Natco Pharma said in a regulatory filing.
Total revenue during the period under review stood at ₹ 583.5 crore. It was at ₹ 432.2 crore in the year-ago quarter. The company said its board of directors at its meeting on Monday had approved the buyback of fully paid-up equity shares of face value of ₹ 2 each at a price not exceeding ₹ 1,000 per share for an aggregate amount of ₹ 2,50 crore from the open market through stock exchange mechanism. The maximum buyback size represents 8.10 per cent and 8.22 per cent of the aggregate of the total paid up equity capital and free reserves, respectively, of the company, it added.
You May Interested In
High Quality β-Nicotinamide adenine dinucleotide CAS 53-84-9 NADwith ready stock and best price
$3/UNIT FOB
2026-10-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Fuhrmann Hanlin Reports Strong Performance in the First Three Quarters of 2023
-
Chinese pharmaceutical companies enter overseas to record with up to $5 billion in licensing fees!
-
Roche's TIGIT Monoclonal Antibody Collapses Again, And A Large Number of Domestic Biopharmaceutical Companies are Deployed
-
Yantai Development Zone builds an integrated industrial chain of pharmaceutical R&D and manufacturing to promote the industrialization of new biological drugs
-
Why Chinese biopharmaceutical companies building factories to expand production
-
Kemira Acquires AquaBlue
-
India Swings the Tariff Axe at Made-in-China: Epoxy Resins Are Just the Beginning—The Road for Chinese Chemicals Abroad Is No Longer Smooth
-
Honeywell Acquires Johnson Matthey Catalyst Business at a Discount, Cutting £475 Million from the Price
-
Japan Begins Construction of the World’s Largest Commercial Liquid Hydrogen Receiving Terminal
-
BASF Raises European NPG and HDO Prices by Up to €300/Tonne as Costs Climb
Recommend Reading
-
![Solvay's]()
Solvay's "Slimming Action": Soda Ash Production Capacity in Spain Slashed by 180,000 Tons, 77 Jobs to Go
-
![India Launches Concentrated Anti-Dumping Actions Against Eight Categories of Chinese Chemicals, Covering APIs/Intermediates, Polyurethanes, and Refrigerants]()
India Launches Concentrated Anti-Dumping Actions Against Eight Categories of Chinese Chemicals, Covering APIs/Intermediates, Polyurethanes, and Refrigerants
-
![Hormuz Sees at Least 12 Vessel Incidents in One Week as Traffic Falls to Two-Month Low]()
Hormuz Sees at Least 12 Vessel Incidents in One Week as Traffic Falls to Two-Month Low
-
![West Asia Tensions Squeeze Pharma Raw Materials]()
West Asia Tensions Squeeze Pharma Raw Materials
-
![IPEC Updates Excipient Qualification Guidance]()
IPEC Updates Excipient Qualification Guidance
-
![China’s New Food-Contact Standards Take Effect, Resetting Compliance for Coatings and Silicone Rubber]()
China’s New Food-Contact Standards Take Effect, Resetting Compliance for Coatings and Silicone Rubber
-
![Business Society September 28, 2026 Maleic Anhydride Trend Analysis: Volatility]()
Business Society September 28, 2026 Maleic Anhydride Trend Analysis: Volatility
-
![Business Society September 29, 2026 Propylene Oxide Trend Analysis: Volatility]()
Business Society September 29, 2026 Propylene Oxide Trend Analysis: Volatility
-
![Business Society September 29, 2026 Phthalic Anhydride Trend Analysis: Strong Rebound with a Bullish Bias]()
Business Society September 29, 2026 Phthalic Anhydride Trend Analysis: Strong Rebound with a Bullish Bias
-
![Premium Global Chemical Sourcing Requests (5-9 Jan, 2026)]()
Premium Global Chemical Sourcing Requests (5-9 Jan, 2026)
